-
2
-
-
0002203791
-
Economics of glycoprotein IIb/IIIa inhibition
-
Lincoff AM, Topol EJ, editors. Contemporary cardiology: platelet glycoprotein IIb/IIIa inhibitors in cardiovascular disease. Totowa (NJ): Humana Press Inc
-
(1999)
, pp. 253-266
-
-
Mark, D.B.1
-
3
-
-
0002321256
-
Medical economics in cardiovascular medicine
-
Topol EJ, editor. Textbook of cardiovascular medicine. New York: Lippincott-Raven
-
(1997)
, pp. 1033-1062
-
-
Mark, D.B.1
-
4
-
-
0033566637
-
Time course, magnitude and consistency of platelet inhibition of abciximab, tirofiban or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention
-
(1999)
Am J Cardiol
, vol.84
, pp. 391-395
-
-
Kereiakes, D.J.1
Broderick, T.M.2
Roth, E.M.3
-
5
-
-
2242477091
-
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty
-
(1994)
N Engl J Med
, vol.330
, pp. 956-961
-
-
-
6
-
-
1842369101
-
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
-
(1994)
N Engl J Med
, vol.336
, pp. 1689-1696
-
-
-
8
-
-
0032508297
-
Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with the use of platelet glycoprotein IIb/IIIa blockade
-
(1998)
Lancet
, vol.352
, pp. 87-92
-
-
-
9
-
-
0033547597
-
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicenter randomized trial
-
(1999)
Lancet
, vol.354
, pp. 2019-2024
-
-
Topol, E.J.1
Mark, D.B.2
Lincoff, A.M.3
-
10
-
-
0000656559
-
Effects of competitive platelet glycoprotein IIb/IIIa inhibition with integrilin in reducing complications of percutaneous coronary intervention
-
(1997)
Lancet
, vol.349
, pp. 1422-1428
-
-
-
11
-
-
0343376106
-
Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis
-
(1997)
Circulation
, vol.96
, pp. 1445-1453
-
-
-
13
-
-
0030918995
-
Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
-
(1997)
Lancet
, vol.349
, pp. 1429-1435
-
-
-
14
-
-
0008926519
-
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes without persistent ST-segment elevation
-
(1998)
N Engl J Med
, vol.339
, pp. 436-443
-
-
-
17
-
-
3543135271
-
Tutorial in biostatistics: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
-
(1998)
Stat Med
, vol.17
, pp. 2265-2281
-
-
D'Agostino R.B., Jr.1
-
20
-
-
0002013325
-
Time preference
-
Gold MR, Siegel JE, Russell LB, et al, editors. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press
-
(1996)
, pp. 214-246
-
-
Lipscomb, J.1
Weinstein, M.C.2
Torrence, G.W.3
|